Impact of the COVID-19 pandemic on ST – elevation myocardial infarction management in a reference center of northern Peru
Objective. To evaluate the impact of the COVID-19 pandemic on the ST–Elevation myocardial infarction (STEMI) management in a reference center of northern Peru. Methods. Observational, analytical, retrospective cohort-type study, derivated from the Acute Coronary Syndrome registry of the Almanzor Agu...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | Perú |
| Recursos: | Instituto Nacional Cardiovascular |
| Repositorio: | Archivos peruanos de cardiología y cirugía cardiovascular |
| Idioma: | español inglés |
| OAI Identifier: | oai:apcyccv.org.pe:article/148 |
| Acesso em linha: | https://apcyccv.org.pe/index.php/apccc/article/view/148 |
| Access Level: | acceso abierto |
| Palavra-chave: | Infarto del miocardio covid-19 reperfusión miocárdica Myocardial infarction COVID-19 Myocardial reperfusion |
| Resumo: | Objective. To evaluate the impact of the COVID-19 pandemic on the ST–Elevation myocardial infarction (STEMI) management in a reference center of northern Peru. Methods. Observational, analytical, retrospective cohort-type study, derivated from the Acute Coronary Syndrome registry of the Almanzor Aguinaga Asenjo National Hospital. The characteristics of the patients with STEMI and their 30-day outcomes were compared in 02 cohorts according to the time of medical care: prior to the pandemic or during the pandemic. Results. During the COVID-19 pandemic, hospitalizations for STEMI decreased by 53%, there was a greater use of fibrinolysis to the detriment of primary angioplasty, with increases in the time of first medical contact (100 vs. 240 minutes, p = 0.006) and ischemic time to percutaneous coronary intervention (900 vs. 2880 minutes, p <0.001). This generated a higher frequency of post-infarction heart failure (21.1% vs. 46.7%, p = 0.002) and a lower left ventricular ejection fraction at discharge (49.2 +/- 8.6 vs 44.8 +/- 9.3, p = 0.009), without an increase in in-hospital cardiovascular mortality. Conclusions. The COVID-19 has had a negative impact on the treatment of patients with STEMI. We found less hospitalizations, prolonged reperfusion times, and higher frequency of post-infarction heart failure and lower left ventricular ejection fraction at discharge. |
|---|